Clinical trial
The Effects of Ezetimibe/Simvastatin 10/20 mg Versus Simvastatin 40 mg in High…
NCT00423579 · Organon and Co, Industry · Completed
Key facts
| NCT number | NCT00423579 |
|---|---|
| Title | The Effects of Ezetimibe/Simvastatin 10/20 mg Versus Simvastatin 40 mg in High Cholesterol and Coronary Heart Disease Study (P04039AM2)(COMPLETED) |
| Official title | A Multicenter, Randomized, Parallel-Groups, Double-Blind Placebo-Controlled Study Comparing the Efficacy, Safety, and Tolerability of Administration of Ezetimibe/Simvastatin Tablet 10/20 mg Versus Doubling the Dose of Simvastatin 20 mg [Simvastatin 40 mg] in Subjects With Primary… |
| Lead sponsor | Organon and Co, Industry |
| Collaborators | Schering-Plough Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hypercholesterolemia, Coronary Disease |
| Intervention type | Drug |
| Interventions | Ezetimibe/Simvastatin 10/20 mg, simvastatin 40 mg |
| Enrollment | 120 |
| Start date | Jul 1, 2006 |
| Primary completion | Mar 1, 2008 |
| Completion | Mar 1, 2008 |
| First posted | Jan 18, 2007 |
| Last update posted | May 22, 2024 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: